November 18, 2024 – Johnson & Johnson MedTech introduced that the U.S. Meals & Drug Administration (FDA) has accredited the OTTAVA™ Investigational Robotic Surgical Techniques (IDE) Gadget Waiver, permitting the medical trial to start at U.S. websites. The corporate will now put together medical trial websites to obtain OTTAVA programs, enroll sufferers and provoke surgical circumstances.

The OTTAVA system is designed to set a brand new customary for the fashionable working room (OR) and rework the surgical expertise. The system's distinctive unified structure, surgical instrumentation powered by Ethicon's experience and Johnson & Johnson MedTech's digital ecosystem are supposed to offer versatility to fulfill the wants of every affected person's care and medical strategy to each surgeon.

The OTTAVA system has 4 unobtrusive robotic arms which are constructed into the working desk and will be saved beneath. This unified structure supplies a compact footprint designed to help robotic, laparoscopic, hybrid and open surgical procedure with extra workspace for medical groups.

Johnson & Johnson MedTech is constructing on its world portfolio of surgical applied sciences to advance OTTAVA and assist surgical groups and hospitals convey the advantages of robotic surgical procedure to extra sufferers. The system is designed to deal with unmet wants that stay in robotic surgical procedure at the moment, whereas driving alternative and competitors in an under-penetrated and quickly rising market.

Proceed studying